On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Hep-Art Medical Devices BV's own share of each project, not the project's full budget.
- FP7 (2007 to 2013)€1.2M · 1 project
- Horizon 2020€50k · 1 project
Projects
2 EU-funded projects, newest first. Hep-Art Medical Devices BV led 1 of them as coordinator. Each links to the official record.
- BALXPANDCoordinator
The HepaRG-Bio-Artificial Liver: Feasibility of commercialization and expansion of business plan
Horizon 2020 · 2017–2017 · Project on CORDIS ↗
€50ktheir share - BALANCEPartner
Development of a bioartificial liver therapy in acute liver failure
FP7 (2007 to 2013) · 2012–2015 · Project on CORDIS ↗
€1.2Mtheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
Fields it works in
Research fields recorded on its Horizon projects.
- bioartificial liver
- bioreactors
- ecosystems
- manufacturing engineering
- transplantation
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗